Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Conditions
- Advanced Leiomyosarcoma
- Adipocytic Sarcoma
- Advanced Liposarcoma
Interventions
- DRUG: Zanzalintinib
- DRUG: Eribulin
Sponsor
Washington University School of Medicine
Collaborators